Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase.
Pinto DS, Frederick PD, Chakrabarti AK, Kirtane AJ, Ullman E, Dejam A, Miller DP, Henry TD, Gibson CM; National Registry of Myocardial Infarction Investigators. Pinto DS, et al. Among authors: miller dp. Circulation. 2011 Dec 6;124(23):2512-21. doi: 10.1161/CIRCULATIONAHA.111.018549. Epub 2011 Nov 7. Circulation. 2011. PMID: 22064592
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions.
Simpfendorfer C, Kottke-Marchant K, Lowrie M, Anders RJ, Burns DM, Miller DP, Cove CS, DeFranco AC, Ellis SG, Moliterno DJ, Raymond RE, Sutton JM, Topol EJ. Simpfendorfer C, et al. Among authors: miller dp. Circulation. 1997 Jul 1;96(1):76-81. doi: 10.1161/01.cir.96.1.76. Circulation. 1997. PMID: 9236420 Clinical Trial.
Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.
Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A, Schweiger M, Cabin H, Davison R, Miller D, et al. Mueller HS, et al. Among authors: miller d. Circulation. 1992 Apr;85(4):1254-64. doi: 10.1161/01.cir.85.4.1254. Circulation. 1992. PMID: 1555269 Clinical Trial.
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators.
Migrino RQ, Young JB, Ellis SG, White HD, Lundergan CF, Miller DP, Granger CB, Ross AM, Califf RM, Topol EJ. Migrino RQ, et al. Among authors: miller dp. Circulation. 1997 Jul 1;96(1):116-21. doi: 10.1161/01.cir.96.1.116. Circulation. 1997. PMID: 9236425 Clinical Trial.
14,582 results
You have reached the last available page of results. Please see the User Guide for more information.